Lancashire and South Cumbria
Formulary
 
back
9 Nutrition and blood

This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net. 

For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/

09-02-01-01 Oral potassium

Potassium chloride with potassium bicarbonate Sando-K®
First Choice

Effervescent tablets potassium 470 mg (12 mmol of K+) and chloride 285mg (8 mmol of Cl-)

Green View adult BNF  View SPC online  View childrens BNF
Potassium Chloride
Second Choice

m/r tablets 600mg (potassium 8 mmol)

Avoid unless effervescent tablets or liquid preparations inappropriate.

Green View adult BNF  View SPC online  View childrens BNF
Potassium Chloride oral liquid
Second Choice

Unlicensed potassium chloride oral solutions manufactured within the UK are available via Specials manufacturers, lead times vary.

Care is needed to ensure selection of the most appropriate oral potassium supplement and delivery of the correct dosage.
 
This National Patient Safety Alert provides further background, clinical information and actions for providers.
Link  CAS: UPDATE: Discontinuation of Kay-Cee-L (potassium chloride 375mg/ml) (potassium chloride 5mmol/5ml) syrup

Green View adult BNF  View SPC online  View childrens BNF